Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease

被引:6
|
作者
Qian, Qi [2 ]
Chen, Zhong [2 ]
Ma, Genshan [1 ,2 ]
Jiang, Yibo [2 ]
Feng, Yi [2 ]
Shen, Chengxing [2 ]
Yao, Yuyu [2 ]
Ding, Jiandong [2 ]
Dai, Qiming [2 ]
Li, Yongjun [2 ]
机构
[1] Southeast Univ, Affiliated Zhongda Hosp, Dept Cardiol, Nanjing 210009, Peoples R China
[2] Southeast Univ, Clin Med Coll, Nanjing 210009, Peoples R China
关键词
Single nucleotide polymorphism; Coronary artery disease; Early-onset; Gene polymorphism; Complement factor H; MACULAR DEGENERATION; MYOCARDIAL-INFARCTION; VARIANT Y402H; ASSOCIATION; GENE; ATHEROSCLEROSIS;
D O I
10.1007/s11033-008-9306-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Inflammation plays an important role in coronary artery disease (CAD). Complement Factor H (CFH) gene has been analyzed in relation to CAD in several studies with conflicting results. The aim of the present study was to investigate the association between the CFH Y402H polymorphism and CAD in Chinese. Methods and results About 336 patients were enrolled, included 166 patients with CAD and 170 controls. The SNP at CFH Y402H was genotyped by ligase detection reaction and plasma levels of CFH were assayed by enzyme-linked immunosorbent assay. Analysis of genotype frequencies did not reveal any significant difference between CAD patients and controls. There were significant differences in the frequencies of C allele and C allele carriers between early-onset CAD and controls. After adjustment of clinical parameters, significant association was identified for CFH Y402H polymorphism, with C allele carriers having a higher risk of early-onset CAD than carriers of TT genotype (odds ratio [OR] 4.66, 95% CI: 1.23-17.62, P = 0.02). There was no difference of plasma CFH levels between CAD group and controls. Conclusions CFH Y402H polymorphism is associated with early-onset CAD in Chinese.
引用
收藏
页码:1257 / 1261
页数:5
相关论文
共 50 条
  • [21] The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors
    Stark, Klaus
    Neureuther, Katharina
    Sedlacek, Kamil
    Hengstenberg, Wibke
    Fischer, Marcus
    Baessler, Andrea
    Wiedmann, Silke
    Jeron, Andreas
    Holmer, Stephan
    Erdmann, Jeanette
    Schunkert, Heribert
    Hengstenberg, Christian
    CLINICAL SCIENCE, 2007, 113 (3-4) : 213 - 218
  • [22] Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy
    Gigante, Paul R.
    Kotchetkov, Ivan S.
    Kellner, Christopher P.
    Haque, Raqeeb
    Ducruet, Andrew F.
    Hwang, Brian Y.
    Solomon, Robert A.
    Heyer, Eric J.
    Connolly, E. Sander
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (03) : 247 - 253
  • [23] Complement Factor H Y402H and C-Reactive Protein Polymorphism and Photodynamic Therapy Response in Age-Related Macular Degeneration
    Feng, Xuefeng
    Xiao, Jing
    Longville, Brooke
    Tan, Alexander X. J.
    Wu, Xia Ni
    Cooper, Matthew N.
    McAllister, Ian L.
    Isaacs, Timothy
    Palmer, Lyle J.
    Constable, Ian J.
    OPHTHALMOLOGY, 2009, 116 (10) : 1908 - 1912
  • [24] Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
    Lee, A. Y.
    Raya, A. K.
    Kymes, S. M.
    Shiels, A.
    Brantley, M. A., Jr.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (05) : 610 - 613
  • [25] Complement Factor H Y402H Variant and Risk of Age-Related Macular Degeneration in Asians: A Systematic Review and Meta-Analysis
    Kondo, Naoshi
    Bessho, Hiroaki
    Honda, Shigeru
    Negi, Akira
    OPHTHALMOLOGY, 2011, 118 (02) : 339 - 344
  • [26] The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS study
    Doney, A. S. F.
    Leese, G. P.
    Olson, J.
    Morris, A. D.
    Palmer, C. N. A.
    DIABETIC MEDICINE, 2009, 26 (05) : 460 - 465
  • [27] Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients
    Buraczynska, Monika
    Ksiazek, Piotr
    Zukowski, Pawel
    Benedyk-Lorens, Ewa
    Orlowska-Kowalik, Grazyna
    CLINICAL IMMUNOLOGY, 2009, 132 (02) : 285 - 290
  • [28] CFH Y402H polymorphism in Italian patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease
    Sodi, Andrea
    Passerini, Ilaria
    Bacherini, Daniela
    Boni, Luca
    Palchetti, Simona
    Murro, Vittoria
    Caporossi, Orsola
    Mucciolo, Dario Pasquale
    Franco, Fabrizio
    Vannozzi, Lorenzo
    Torricelli, Francesca
    Pelo, Elisabetta
    Rizzo, Stanislao
    Virgili, Gianni
    OPHTHALMIC GENETICS, 2018, 39 (06) : 699 - 705
  • [29] Proteomic genotyping of SNP of Complement Factor H (CFH) Y402H and I62V using multiple reaction monitoring (MRM) assays
    Kim, Kyoung Lae
    Kim, Hyerim
    Lee, Youngju
    Lee, Cheolju
    Joo, Kwangsic
    Park, Sang Jun
    Park, Kyu Hyung
    Park, Seong-Jun
    Woo, Se Joon
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis
    Roshanshad, Amirhossein
    Moosavi, Seyed Ali
    Arevalo, J. Fernando
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 358 - 386